Clinical Trial Update: Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction (DIAMONDHFpEF)

View source ↗

Summary

Update on the DIAMONDHFpEF trial assessing imaging and plasma biomarkers to describe heart failure with preserved ejection fraction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: University of Leicester | Conditions: Patients With Heart Failure and Preserved Ejection Fraction - HFpEF, Patients With Heart Failure With Reduced Ejection Fraction - HFrEF | Status: COMPLETED